Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Tvardi Therapeutics, Incorporated

Clinical trials sponsored by Tvardi Therapeutics, Incorporated, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New hope for advanced liver cancer: experimental drug TTI-101 enters Mid-Stage trials Results expected Feb 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Completed 1

New hope for advanced liver cancer: experimental drug TTI-101 enters Mid-Stage trials

Disease control Recruiting now

This study tests a new oral drug called TTI-101 in people with advanced liver cancer that cannot be removed by surgery. The drug is given alone or combined with standard immunotherapy drugs. The main goals are to check safety and see if the drug shrinks tumors. About 193 adults w…

Phase 1/2 • Sponsor: Tvardi Therapeutics, Incorporated • Aim: Disease control

Last updated Jun 27, 2026 12:24 UTC